Does olanzapine have antidepressant properties? A retrospective preliminary study

Bipolar Disorders

Volumn 2, Issue 3 PART 1, 2000, Pages 196-199

  Ghaemi, S Nassir ^a,b   Cherry, Erica L ^b   Katzow, Jacob A ^b   Goodwin, Frederick K ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Bipolar disorder; Depression; Drug therapy; Mood disorders; Mood stabilizers; Olanzapine

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE; PIRENZEPINE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRENZEPINE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034278774     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2000.020307.x     Document Type: Article

References (16)

1. Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 1996; 16 (Suppl. 1): 32S-47S.
2. Tohen M, Sanger T, McElroy S et al. Olanzapine vs. placebo in the treatment of acute mania. Am J Psychiatry 1999; 156: 702-709.
3. Tohen M. Olanzapine in the treatment of acute mania (abstract). In: 3rd International Conference on Bipolar Disorder. Pittsburgh, Pennsylvania, 1999.
4. Hertel P, Nomikos GG, Schilstrom B, Arborelius L, Svensson TH. Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha-2 receptor antagonism. Neuropsychopharmacology 1997; 17: 44-55.
5. Blier P, Bergeron R, de Montigny C. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Neuropsychopharmacology 1997; 16: 333-338.
6. Tollefson GD, Beasley CM, Tran PV et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaboration. Am J Psychiatry 1997; 154: 457-465.
7. Tohen M, Sanger TM, Tollefson GD, McElroy SL. Olanzapine versus haloperidol in the treatment of schizoaffective bipolar patients (abstract). In: 2nd International Conference on Bipolar Disorder. Pittsburgh, Pennsylvania, 1997.
8. Zarate CA, Narendran R, Tohen M et al. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry 1998; 59: 24-28.
9. Rothschild A, Bates K, Boehringer K, Syed A. Olanzapine response in psychotic depression (abstract). In: 36th American College of Neuropsychopharmacology. Waikoloa, Hawaii, December, 1997.
10. Koenig F, Barg T, Gruenewald I, Petersdorff T, Kaschka W, Braun S. Combined therapy using SSRIs with neuroleptics in delusional depression (abstract). In: Annual meeting of the American Psychiatric Association. Toronto, Ontario, 1998.
11. Shelton R, Tollefson G, Tohen M. The study of olanzapine plus fluoxetine in treatment-resistant major depressive disorder without psychotic features (abstract). In: 38th annual New Clinical Drug Evaluation Unit (NCDEU) Meeting. Boca Raton, Florida, 1999.
12. Hillert A, Maier W, Wetzel H, Benkert O. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome - a functional approach. Pharmacopsychiatry 1995; 25: 213-217.
13. Keck PE Jr, Wilson DR, Strakowski SM et al. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 1995; 56: 466-471.
14. Muller-Siechender F, Muller M, Hillert A, Szegedi A, Wetzel H, Benkert O. Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. J Clin Psychopharmacol 1998; 18: 111-120.
15. London J. Mania associated with olanzapine (letter). JAm Acad Child Adolesc Psychiatry 1998; 37: 997-1008.
16. Dwight MM, Keck PE, Stanton SP, Strakowski SM, McElroy SL. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder (letter). Lancet 1994; 344: 554-555.